BioPharmSignal logoBioPharmSignal

Biotech News

Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

Humana (HUM)HumanaFinancing

LOUISVILLE, Ky. --(BUSINESS WIRE)--Mar. 5, 2026-- Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the

Related news

HUMHumana2026-03-09 21:00 EST

Humana Completes Aggregate $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

HUMHumana2026-08-20 11:00 EST

Humana Names Dr. Shantanu Nundy as Chief Medical Officer

View all latest news

Humana

Senior-Focused Health Insurance Humana is a health and wellness company centered on Medicare Advantage and other government-sponsored health plans. Its insurance operations coordinate benefits, provider networks and care programs for seniors and other eligible populations. Medicare Advantage Platform Individual Medicare Advantage is the...

Recent company news

HUMHumana2026-08-20 11:00 EST

Humana Names Dr. Shantanu Nundy as Chief Medical Officer

HUMHumana2026-07-29 11:00 EST

Humana Elects Paul Smith and Frederick Crawford to Board of Directors

HUMHumana2026-07-29 10:00 EST

Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

HUMHumana2026-06-22 20:30 EST

Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026

HUMHumana2026-06-10 20:30 EST

Humana Announces Agreement to Divest Minority Interest in Gentiva

Stock data

Close
378.88 USD
Market cap
38.53B USD
Exchange
NYSE
Sector
Biopharma
Location
United States